Unmet Needs With Recurrent C Difficile Infections

The panelist discusses how recurrent Clostridioides difficile infections represent a critical health care challenge, characterized by unmet needs in long-term prevention, microbiome restoration, and personalized treatment. The field is evolving toward precision medicine approaches, leveraging advanced diagnostics, innovative therapeutic modalities such as engineered probiotics and bacteriophage therapies, and comprehensive strategies that integrate microbial, immunological, and genetic insights to improve patient outcomes.

EP: 1.The Role of Testing for C Difficile in Clinical Practice

EP: 2.Utilizing Antibiotics in Treatment of C Difficile

EP: 3.Examining FMT for Patients With Recurrent C Difficile infections

EP: 4.Exploring Rebyota for Recurrent C Difficile Infections

EP: 5.Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections

EP: 6.Vowst as a Potential Option for Patients With Recurrent C Difficile Infections

EP: 7.Management of Recurrent C Difficile Infections in the Future

EP: 8.Key Background Information on Recurrent C. Difficile Infections

EP: 9.Importance of Early Detection of Recurrent C Difficile Infections

EP: 10.Impact of Recurrent C Difficile Infection on Costs and Patient Quality of Life

EP: 11.Diagnosis of Recurrent C Difficile Infections

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections

Now Viewing

EP: 13.Unmet Needs With Recurrent C Difficile Infections

Video content above is prompted by the following:

What are the main unmet needs for recurrent C difficile infections and how do you see the field evolving in the future?

Related Videos

Related Content

Advertisement

February 20th 2025

Abortion in 2025: Access, Fertility, and Infant Mortality Updates

Giuliana Grossi

While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 19th 2025

What Recent Evidence Is Telling Us About Alcohol and Cancer

Produced by Mary Caffrey

Evidence shows alcohol increases estrogen, raising breast cancer risk, with pandemic-related consumption spikes among women.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 18th 2025

Sugammadex Safe, Effective Post Surgery in Myasthenia Gravis

Maggie L. Shaw

Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was approved by the FDA in 2015 to reverse the anesthesia-induced neuromuscular blockade from rocuronium bromide or vecuronium bromide.

February 18th 2025

Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC

Mary Caffrey

Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).

Related Content

Advertisement

February 20th 2025

Abortion in 2025: Access, Fertility, and Infant Mortality Updates

Giuliana Grossi

While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 19th 2025

What Recent Evidence Is Telling Us About Alcohol and Cancer

Produced by Mary Caffrey

Evidence shows alcohol increases estrogen, raising breast cancer risk, with pandemic-related consumption spikes among women.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 18th 2025

Sugammadex Safe, Effective Post Surgery in Myasthenia Gravis

Maggie L. Shaw

Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was approved by the FDA in 2015 to reverse the anesthesia-induced neuromuscular blockade from rocuronium bromide or vecuronium bromide.

February 18th 2025

Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC

Mary Caffrey

Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).